跳至主要内容
临床试验/IRCT20231028059882N2
IRCT20231028059882N2招募中3 期

Effect of Astaxanthin on Advanced Glycation End Products (AGE)-Receptor for AGE (RAGE)-Inflammation Signaling pathway in Women with Polycystic Ovarian Syndrome-Associated Infertility

Tehran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 38 years(—)
性别
Female

入选标准

  • Aged between 20 to 38 years old
  • Body mass index (BMI)= 20-30
  • Polycystic ovary syndrome (PCOS) diagnosis based on the Rotterdam criteria
  • Assisted reproductive technology (ART) candidate due to anovulatory infertility
  • Controlled ovulation stimulation (COS) by GnRH-Antagonist protocol

排除标准

  • Pregnancy or abortion during the last year before the start of the study
  • History of other endocrinopathies such as adrenal hyperplasia, androgen-secreting tumors, hyperprolactinemia, thyroid dysfunction, diabetes, or impaired glucose tolerance
  • Coexistence of other causes of infertility (severe male factor, tubal factor, uterine factor, endometriosis, Asherman syndrome, diminished ovarian reserves, etc.)
  • Consumption of herbal or traditional medicine, antioxidant supplements, and vitamins within three months before the start of the study
  • Taking ovulation-induction drugs, hormonal agents, and metformin within three months before the start of the study

研究者

相似试验